Evidence map›Paper›PMID 40302729›Full record

ArticleOpen forum infectious diseases2025

Clinical Characteristics and Factors Associated With Severe Outcomes of 1891 Pediatric Patients Admitted to the Referral Cholera Treatment Centers in Lusaka, Zambia, December 2023-March 2024.

Nawa Kalima, Tadatsugu Imamura, Ilunga Chambah, Nyuma Mbewe, Annel Sinkala, Chalilwe Chungu, Khozya Zyambo, Paul Msanzya Zulu, Kelvin Mwangilwa, Muzala Kapin'a and 12 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Nawa KalimaNational Heart Hospital, Lusaka, Zambia.ORCID https://orcid.org/0009-0001-5133-0830
Tadatsugu ImamuraJapan International Cooperation Agency, Tokyo, Japan.
Ilunga ChambahDepartment of Pediatrics, University Teaching Hospital, Lusaka, Zambia.
Nyuma MbeweZambia National Public Health Institute, Lusaka, Zambia.ORCID https://orcid.org/0000-0002-3309-0538
Annel SinkalaAdult Infectious Diseases Center, University Teaching Hospital, Lusaka, Zambia.ORCID https://orcid.org/0009-0003-4463-5614
Chalilwe ChunguZambia Paediatric Association, Lusaka, Zambia.
Khozya ZyamboZambia Paediatric Association, Lusaka, Zambia.ORCID https://orcid.org/0000-0002-3813-2784
Paul Msanzya ZuluZambia National Public Health Institute, Lusaka, Zambia.ORCID https://orcid.org/0000-0002-2653-4428
Kelvin MwangilwaZambia National Public Health Institute, Lusaka, Zambia.
Muzala Kapin'aZambia National Public Health Institute, Lusaka, Zambia.
Anchingika MugalaLevy Mwanawasa University Teaching Hospital, Lusaka, Zambia.
Kabaso MwewaAdult Infectious Diseases Center, University Teaching Hospital, Lusaka, Zambia.ORCID https://orcid.org/0009-0000-1594-8556
Paul MashangaLevy Mwanawasa University Teaching Hospital, Lusaka, Zambia.
Natasha NgwenyaLevy Mwanawasa University Teaching Hospital, Lusaka, Zambia.
Bob ChirwaAdult Infectious Diseases Center, University Teaching Hospital, Lusaka, Zambia.
Shingo MitsushimaCenter for Field Epidemic Intelligence, Research and Professional Development, National Institute of Infectious Diseases, Tokyo, Japan.
Yuuki TsuchihashiCenter for Field Epidemic Intelligence, Research and Professional Development, National Institute of Infectious Diseases, Tokyo, Japan.
Taro KamigakiCenter for Surveillance, Immunization, and Epidemiologic Research, National Institute of Infectious Diseases, Tokyo, Japan.ORCID https://orcid.org/0000-0002-3612-4270
Aggrey MweembaCatholic Relief Services Zambia, Programming and Health, Lusaka, Zambia.
Nathan KapataZambia National Public Health Institute, Lusaka, Zambia.
Roma ChilengiZambia National Public Health Institute, Lusaka, Zambia.
Lloyd MulengaAdult Infectious Diseases Center, University Teaching Hospital, Lusaka, Zambia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Zambia declared a cholera outbreak on 18 October 2023 and, as of 31 June 2024, had recorded 23 381 cases and 740 deaths. Of the patients seen at the 2 main cholera treatment centers in the capital Lusaka, a third of them were children aged 0 to 15 years. Despite the significant pediatric cholera burden, risk factors for mortality and prolonged hospitalization remain unknown. Methods: A retrospective data review was conducted by examining the clinical characteristics of patients aged 0 to 15 years hospitalized at the 2 cholera treatment centers between 15 October 2023 and 31 March 2024. Descriptive analysis was conducted for patient characteristics, and penalized logistic regression (PLR) was used to analyze risk factors for the outcomes. Results: A total of 1891 patients were identified, among which 1.4% (18/1253) had fatal outcomes and 47.9% (399/833) had hospitalization >2 days. By the PLR, the following factors were independently correlated with hospitalization >2 days: HIV infection (odds ratio [OR], 6.89; 95% CI, 1.32-71.9), severe acute malnutrition (SAM; OR, 10.8; 95% CI, 2.91-61.1), and dehydration treatment plans B (OR, 3.93; 95% CI, 1.80-9.27) and C (OR, 7.54; 95% CI, 2.71-22.9). For the fatal outcome, none of them independently showed any significant correlations by the PLR, although younger age and SAM were positively associated by bivariate analysis. Conclusions: Comorbidities such as SAM and HIV, being on plan B or C, and deteriorating and requiring more intense treatment are associated with longer hospitalization. Risk factors for mortality need to be further investigated.

Indexed as

cholera treatment centersclinical outcomesHIVpediatric patientssevere acute malnutrition

Identifiers

PMID40302729
PMCPMC12039484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.